The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Attracting quality publishers takes more than just a signup form. Smart visibility, trust-building, and consistent follow-through - this is what works. Here's a 6-step guide based on what's worked for ...

Veeva Systems today released the latest insights from its Veeva Pulse Field Trends Report, showing effective content-driven ...

In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on ...

Hanmi Pharmaceutical collaborates with Merck (MSD) to evaluate the combination therapy of its immune anticancer drug candidate and MSD's immune anticancer drug "Keytruda" (ingredient name ...

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Reuters FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to ...

HYDERABAD, India (Reuters) - Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company ...

HYDERABAD, India, Feb 26 (Reuters) - Drugmaker Merck (MRK.N), opens new tab, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the ...

The recent funding marks the first investment of U.S. pharma giant Merck Sharp & Dohme (MSD) in a health tech startup in Asia Pacific. (MSD is the brand that Merck uses to operate outside the U.S ...

Shares in Merck – known outside North America as MSD – tumbled after the drugmaker said it was halting shipments of a top-selling vaccine to China to help a key local supplier reduce excess ...

A Merck KGaA brand logo stands in front of the company premises ... announced on 06 January the sale of its WuXi Vaccines facility in Ireland to MSD International, a subsidiary of Merck & Co ...